Phelan discovered a My-T-BCR super complex: compared with other ABC DLBCL and GCB DLBCL cell lines, the survival rate of MYD88 L265P and CD79A mutant or CD79B mutant ABC DLBCL cell lines is more dependent on this complex (Phelan et al., 2018). The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.